Steffie M. Vonk
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Real-World Medication Adherence and Medication Reviews in Adults and Children With Cystic Fibrosis.
Journal: Pediatric pulmonology
Published: March 25, 2026
Real-world population pharmacokinetics of tezacaftor-ivacaftor in children with cystic fibrosis: The SYM-CF study.
Journal: British journal of clinical pharmacology
Published: January 13, 2025
Real-world pharmacokinetics of elexacaftor-tezacaftor-ivacaftor in children with cystic fibrosis: a prospective observational study.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 16, 2024
Dried Blood Spot Method Development and Clinical Validation for the Analysis of Elexacaftor, Elexacaftor-M23, Tezacaftor, Tezacaftor-M1, Ivacaftor, Ivacaftor Carboxylate, and Hydroxymethyl Ivacaftor Using LC-MS/MS.
Journal: Therapeutic drug monitoring
Published: January 29, 2024
Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 29, 2024
Stepwise Introduction of Elexacaftor-Tezacaftor-Ivacaftor in Patients With Cystic Fibrosis and Liver Cirrhosis Child-Pugh A or B Using Clinical and Therapeutic Drug Monitoring: A Case Series.
Journal: Clinical therapeutics
Published: September 03, 2023
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer.
Journal: Breast cancer research : BCR
Published: November 15, 2022
Exploring experiences and health-related quality of life of caregivers of patients who start home dialysis: study protocol for a prospective, multicentre cohort study.
Journal: BMJ open
Published: November 10, 2022
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients.
Journal: Pharmacology research & perspectives
Published: August 11, 2022
No drug-drug interaction between tezacaftor-ivacaftor and clofazimine: A case report.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 21, 2021
Tobramycin and vestibulotoxicity: retrospective analysis of four cases.
Journal: European journal of hospital pharmacy : science and practice
Published: November 05, 2020
Last Updated: 09/26/2026